Eosinophilia and Eosinophil-Related Disorders

Middleton's Allergy: Principles and Practice: Eighth Edition

Volumn 2-2, Issue , 2014, Pages 1205-1223

  Klion, Amy D ^a   Weller, Peter F ^b,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898783719     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-08593-9.00076-0     Document Type: Chapter

References (152)

1. Rothenberg ME, Hogan SP The eosinophil. Annu Rev Immunol 2006, 24:147-174.
2. Dvorak AM, Weller PF Ultrastructural analysis of human eosinophils. Chem Immunol 2000, 76:1-28.
3. Loutfy MR, Wilson M, Keystone JS, Kain KC Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002, 66:749-752.
4. Newberry AM, Williams DN, Stauffer WM, et al. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 2005, 128:3681-3684.
5. Mullarkey MF Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol 1988, 82:941-949.
6. Amorim MM, Araruna A, Caetano LB, et al. Nasal eosinophilia: an indicator of eosinophilic inflammation in asthma. Clin Exp Allergy 2010, 40:867-874.
7. Ellis AK, Keith PK Nonallergic rhinitis with eosinophilia syndrome and related disorders. Clin Allergy Immunol 2007, 19:87-100.
8. Baroody FM, Hughes CA, McDowell P, et al. Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg 1995, 121:1396-1402.
9. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?. J Allergy Clin Immunol 2003, 112:877-882.
10. Ryan MW Allergic fungal rhinosinusitis. Otolaryngol Clin North Am 2011, 44:697-710.
11. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990, 323:1033-1039.
12. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000, 356:1480-1485.
13. Birring SS, Parker D, McKenna S, et al. Sputum eosinophilia in idiopathic pulmonary fibrosis. Inflamm Res 2005, 54:51-56.
14. Romagosa R, Kapoor S, Sanders J, Berman B Inpatient adverse cutaneous drug eruptions and eosinophilia. Arch Dermatol 2001, 137:511-512.
15. Junghans RP, Manning W, Safar M, Quist W Biventricular cardiac thrombosis during interleukin-2 infusion. N Engl J Med 2001, 344:859-860.
16. Allen JN Drug-induced eosinophilic lung disease. Clin Chest Med 2004, 25:77-88.
17. Camus P, Fanton A, Bonniaud P, et al. Interstitial lung disease induced by drugs and radiation. Respiration 2004, 71:301-326.
18. Foucher P, Camus P Pneumotox on line: the drug-induced respiratory disease website http://www.pneumotox.com.
19. Souza CA, Muller NL, Johkoh T, Akira M Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients. AJR Am J Roentgenol 2006, 186:368-373.
20. Bullington W, Sahn SA, Judson MA Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci 2007, 333:290-292.
21. Huggins JT, Sahn SA Drug-induced pleural disease. Clin Chest Med 2004, 25:141-153.
22. Fletcher A Eosinophiluria and acute inter-stitial nephritis. N Engl J Med 2008, 358:1760-1761.
23. Barton M, Finkelstein Y, Opavsky MA, et al. Eosinophilic myocarditis temporally associated with conjugate meningococcal C and hepatitis B vaccines in children. Pediatr Infect Dis J 2008, 27:831-835.
24. Schoepfer AM, Engel A, Fattinger K, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007, 47:521-526.
25. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011, 124:588-597.
26. Wolf R, Orion E, Marcos B, Matz H Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005, 23:171-181.
27. Bahrami S, Malone JC, Webb KG, Callen JP Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 2006, 142:155-161.
28. Gil H, Magy N, Mauny F, Dupond JL Valeur de l'eosinopenie dans le diagnostic des syndromes inflammatoires disorders: un "vieux" marquer revisite. Rev Med Interne 2003, 24:431-435.
29. Wilson ME, Weller PF Eosinophilia. Tropical infectious diseases: principles, pathogens and practice 2011, 939-949. Churchill Livingstone, Philadelphia. 3rd ed. R.L. Guerrant, D.H. Walker, P.F. Weller (Eds.).
30. Kim YJ, Nutman TB Eosinophilia: causes and pathobiology in persons with prior exposures in tropical areas with an emphasis on parasitic infections. Curr Infect Dis Rep 2006, 8:43-50.
31. Starr J, Pruett JH, Yunginger JW, Gleich GJ Myiasis due to Hypoderma lineatum infection mimicking the hypereosinophilic syndrome. Mayo Clin Proc 2000, 75:755-759.
32. Centers for Disease Control and Prevention Notes from the field: acute muscular sarcocystosis among returning travelers-Tioman Island, Malaysia. MMWR Morb Mortal Wkly Rep 2012, 61:37-38.
33. Cohen AJ, Steigbigel RT Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996, 174:615-618.
34. Chusid MJ, Dale DC, West BC, Wolff SM The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975, 54:1-27.
35. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006, 117:1292-1302.
36. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010, 126:45-49.
37. Crane MM, Chang CM, Kobayashi MG, Weller PF Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol 2010, 126:179-181.
38. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009, 124:1319-1325.
39. Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003, 101:4660-4666.
40. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003, 348:1201-1214.
41. Metzgeroth G, Walz C, Erben P, et al. Safety and efficacy of imatinib in chronic eosinophilic leukemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol 2008, 143:707-715.
42. Chang HW, Leong KH, Koh DR, et al. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999, 93:1651-1657.
43. Roufosse F, Cogan E, Goldman M Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:389-413.
44. Weller PF, Bubley GJ The idiopathic hypereosinophilic syndrome. Blood 1994, 83:2759-2779.
45. Tai PC, Ackerman SJ, Spry CJ Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987, 1:643-647.
46. Pitini V, Arrigo C, Azzarello D, et al. Serum concentration of cardiac troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes. Blood 2003, 102:3456-3457.
47. Ogbogu PU, Rosing DR, Horne MK Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:457-475.
48. Plastiras SC, Economopoulos N, Kelekis NL, Tzelepis GE Magnetic resonance imaging of the heart in a patient with hypereosinophilic syndrome. Am J Med 2006, 119:130-132.
49. Fuzellier JF, Chapoutot L, Torossian PF Mitral valve repair in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 2004, 13:529-531.
50. Moore PM, Harley JB, Fauci AS Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985, 102:109-114.
51. Barouky R, Bencharif L, Badet F, et al. Mucosal ulcerations revealing primitive hypereosinophilic syndrome. Eur J Dermatol 2003, 13:207-208.
52. McPherson T, Cowen EW, McBurney E, Klion AD Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. Br J Dermatol 2006, 155:824-826.
53. Lefebvre C, Bletry O, Degoulet P, et al. Facteurs pronostiques du syndrome hyperéosinophilique. Étude de 40 observations. Ann Med Interne (Paris) 1989, 140:253-257.
54. Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008, 358:1215-1228.
55. Cooper MA, Akard LP, Thompson JM, Dugan MJ, Jansen J Hypereosinophilic syndrome: long-term remission following allogeneic stem cell transplant in spite of transient eosinophilia post-transplant. Am J Hematol 2005, 78:33-36.
56. Ueno NT, Anagnostopoulos A, Rondon G, et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 2002, 119:131-134.
57. Bain B The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 2004, 89:133-137.
58. Pardanani A, Reeder T, Li CY, Tefferi A Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia. Leuk Res 2003, 27:883-885.
59. Enblad G, Sundstrom C, Glimelius B Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993, 11:187-193.
60. Borish L, Dishuk J, Cox L, et al. Sézary syndrome with elevated serum IgE and hyper-eosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 1993, 92:123-131.
61. Samoszuk M, Ramzi E, Cooper DL Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol 1993, 42:402-404.
62. Wilson F, Tefferi A Acute lymphocytic leukemia with eosinophilia: two case reports and a review of the literature. Leuk Lymphoma 2005, 46:1045-1050.
63. Tancrede-Bohin E, Ionescu MA, de La Salmoniere P, et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol 2004, 140:1057-1061.
64. Staumont-Salle D, Dombrowicz D, Capron M, et al. Eosinophils and urticaria. Clin Rev Allergy Immunol 2006, 30:13-18.
65. Stone JH, Zen Y, Deshpande V IgG4-related disease. N Engl J Med 2012, 366:539-551.
66. Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984, 310:1621-1626.
67. Morgan SJ, Prince HM, Westerman DA, McCormack C, Glapole I Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 2003, 44:1623-1625.
68. Matsuda M, Fushimi T, Nakamura A, Ikeda S Nonepisodic angioedema with eosinophilia: a report of two cases and a review of the literature. Clin Rheumatol 2006, 25:422-425.
69. Yuen HW, Goh YH, Low WK, Lim-Tan SK Kimura's disease: a diagnostic and therapeutic challenge. Singapore Med J 2005, 46:179-183.
70. Kempf W, Haeffner AC, Zepter K, et al. Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol 2002, 33:1023-1029.
71. Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, Persellin S Eosinophilic fasciitis: spectrum of MRI findings. AJR Am J Roentgenol 2005, 184:975-978.
72. Moossavi M, Mehregan DR Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol 2003, 42:62-67.
73. + lymphoproliferative disorder of the oral mucosa: a form of "traumatic eosinophilic granuloma". Am J Clin Pathol 2004, 121:43-50.
74. Rajendran PM, Dolev JC, Heaphy MR, Mauerer T Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 2005, 141:1227-1231.
75. Fernandez Perez ER, Olson AL, Frankel SK Eosinophilic lung diseases. Med Clin North Am 2011, 95:1163-1187.
76. Allen JN, Davis WB Eosinophilic lung diseases. Am J Respir Crit Care Med 1994, 150:1423-1438.
77. Jederlinic PJ, Sicilian L, Gaensler EA Chronic eosinophilic pneumonia: a report of 19 cases and a review of the literature. Medicine (Baltimore) 1988, 67:154-162.
78. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000, 216:773-780.
79. Ross AG, Vickers D, Olds GR, Shah SM, McMans DP Katayama syndrome. Lancet Infect Dis 2007, 7:218-224.
80. Boggild AK, Keystone JS, Kain KC Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity. Clin Infect Dis 2004, 39:1123-1128.
81. Marchand E, Reynaud-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilic pneu-monia: a clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1998, 77:299-312.
82. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969, 280:787-798.
83. Weller PF, Plaut M, Taggart V, Trontell A The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001, 108:175-183.
84. Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997, 155:296-302.
85. Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002, 166:1235-1239.
86. Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002, 166:797-800.
87. Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002, 41:1016-1020.
88. Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004, 292:2997-3005.
89. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine (Baltimore) 1996, 75:334-342.
90. King MA, Pope-Harman AL, Allen JN, Christoforidis GA, Christoforidis AJ Acute eosinophilic pneumonia: radiologic and clinical features. Radiology 1997, 203:715-719.
91. Kalomenidis I, Light RW Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med 2004, 10:289-293.
92. Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 2009, 34:1111-1117.
93. Rubins JB, Rubins HB Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest 1996, 110:1271-1274.
94. Allen JN, Davis WB, Pacht ER Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990, 142:642-647.
95. Boomars KA, Wagenaar SS, Mulder PG, van Vetzen-Blad H, van den Bosch JM Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax 1995, 50:1087-1092.
96. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660-1669.
97. Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-1225.
98. Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996, 28:1-13.
99. Levy AM, Yamazaki K, Van Keulen VP, et al. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Am J Gastroenterol 2001, 96:1522-1528.
100. Kim YK, Kim CS, Moon WS, et al. MRI findings of focal eosinophilic liver diseases. AJR Am J Roentgenol 2005, 184:1541-1548.
101. Golden J, Frim DM, Chapman PH, Vonsettel JP Marked tissue eosinophilia within organizing chronic subdural hematoma membranes. Clin Neuropathol 1994, 13:12-16.
102. Lo Re V, Gluckman SJ Eosinophilic meningitis. Am J Med 2003, 114:217-223.
103. Kargili A, Bavbek N, Kaya A, Kosar A, Karaaslan Y Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases. Rheumatol Int 2004, 24:321-324.
104. Bavbek N, Kargili A, Cipil H, Kosar A, Karaaslan Y Rheumatologic disease with peripheral eosinophilia. Rheumatol Int 2004, 24:317-320.
105. Tay C Eosinophilic arthritis. Rheumatology (Oxford) 1999, 38:1188-1194.
106. Krahn M, Lopez de Munain A, Streichenberger N, et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol 2006, 59:905-911.
107. Kaufman LD, Kephart GM, Seidman RJ, et al. The spectrum of eosinophilic myositis: clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum 1993, 36:1014-1024.
108. Brown JP, Rola-Pleszczynski M, Menard H-A. Eosinophilic synovitis: clinical observations on a newly recognized subset of patients with dermatographism. Arthritis Rheum 1986, 29:1147-1151.
109. Atanes A, Fernandez V, Nunez R, et al. Idiopathic eosinophilic synovitis: case report and review of the literature. Scand J Rheumatol 1996, 25:183-185.
110. Kaufman LD, Krupp LB Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1995, 7:560-567.
111. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78:26-37.
112. Churg A, Brallas M, Cronin SR, Churg J Formes frustes of Churg-Strauss syndrome. Chest 1995, 108:320-323.
113. Bili A, Condemi JJ, Bottone SM, Ryan CK Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists. J Allergy Clin Immunol 1999, 104:1060-1065.
114. Priori R, Tomassini M, Magrini L, Conti F, Valesini G Churg-Strauss syndrome during pregnancy after steroid withdrawal. Lancet 1998, 352:1599-1600.
115. Churg J, Strauss L Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951, 27:277-301.
116. Lanham JG, Elkon KB, Pusey CD, Hughes GR Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984, 63:65-81.
117. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33:1094-1100.
118. Chen KR, Ohata Y, Sakurai M, Nakayama H Churg-Strauss syndrome: report of a case without preexisting asthma. J Dermatol 1992, 19:40-47.
119. Choi YH, Im JG, Han BK, et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000, 117:117-124.
120. Silva CI, Müller NL, Fujimoto K, et al. Churg-Strauss syndrome: high resolution CT and pathologic findings. J Thorac Imaging 2005, 20:74-80.
121. Olsen K, Neel H, DeRemee R, Weiland LH Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss). Otolaryngol Head Neck Surg 1980, 88:85-89.
122. Sehgal M, Swanson JW, DeRemee RA, Colby TV Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995, 70:337-341.
123. Lie JT Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 1995, 21:883-909.
124. Schwartz RA, Churg J Churg-Strauss syndrome. Br J Dermatol 1992, 127:199-204.
125. Tatsis E, Schnabel A, Gross WL Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998, 129:370-374.
126. Chen KR, Su WP, Pittelkow MR, et al. Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 1996, 35:173-182.
127. Lie JT, Michet CJ Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries. Hum Pathol 1988, 19:598-602.
128. Lane SE, Watts RA, Barker TH, Scott DG Evaluation of the Sørensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology (Oxford) 2002, 41:1138-1141.
129. Hunsaker JC, O'Connor WN, Lie JT Is spontaneous dissection of the coronary artery with eosinophilia a limited form of Churg-Strauss syndrome?. Arch Pathol Lab Med 1994, 118:863-864.
130. Huang CY, Lu TM, Hsu CP, et al. Eosinophilia presenting as acute coronary syndrome. Am J Hematol 2004, 76:94-95.
131. Blauwet LA, Breen JF, Edwards WD, Klarich KW Atypical presentation of eosinophilic endomyocardial disease. Mayo Clin Proc 2005, 80:1078-1084.
132. Nolan CRI, Anger MS, Kelleher SP Eosinophiluria: a new method of detection and definition of the clinical spectrum. N Engl J Med 1986, 315:1516-1519.
133. Corwin HL, Korbet SM, Schwartz MM Clinical correlates of eosinophiluria. Arch Intern Med 1985, 145:1097-1099.
134. Verhagen PC, Nikkels PG, de Jong TP Eosinophilic cystitis. Arch Dis Child 2001, 84:344-346.
135. Kilic S, Erguvan R, Ipek D, et al. Eosinophilic cystitis: a rare inflammatory pathology mimicking bladder neoplasms. Urol Int 2003, 71:285-289.
136. Chan MK, Chow L, Lam SS, Jones B Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 1988, 11:180-183.
137. Fontan MP, Rodriguez-Carmona A, Galed I, et al. Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis. Perit Dial Int 2003, 23:460-464.
138. Sowerwine KJ, Holland SM, Freeman AF Hyper-IgE syndrome update. Ann N Y Acad Sci 2012, 1250:25-32.
139. Wada T, Toma T, Okamoto H, et al. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 2005, 106:2099-2101.
140. Mogayzel PJ, Yang SC, Wise BV, Colombani PM Eosinophilic infiltrates in a pulmonary allograft: a case and review of the literature. J Heart Lung Transplant 2001, 20:692-695.
141. Saisu K, Morozumi K, Suzuki K, Fujita K Significance of interstitial lesions as the early indicator for acute vascular rejection in human renal allografts. Clin Transplant 1999, 13:17-23.
142. Nagral A, Quaglia A, Sabin CA, et al. Blood and graft eosinophils in acute cellular rejection of liver allografts. Transplant Proc 2001, 33:2588-2593.
143. Gollub SB, Huntrakoon M, Dunn MI The significance of eosinophils in mild and moderate acute cardiac allograft rejection. Am J Cardiovasc Pathol 1990, 3:21-26.
144. Emovon OE, King JA, Smith SR, et al. Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. Clin Nephrol 2003, 59:367-372.
145. Yousem SA Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Hum Pathol 1996, 27:269-273.
146. Ben-Ari Z, Dhillon AP, Garwood L, et al. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection. Transplant Proc 1996, 28:3624-3628.
147. Nolan CR, Saenz KP, Thomas CA, Murph KD Role of the eosinophil in chronic vascular rejection of renal allografts. Am J Kidney Dis 1995, 26:634-642.
148. de Groen PC, Kephart GM, Gleich GJ, Ludwig J The eosinophil as an effector cell of the immune response during hepatic allograft rejection. Hepatology 1994, 20:654-662.
149. Marra DE, McKee PH, Nghiem P Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 2004, 51:543-546.
150. Beishuizen A, Vermes I, Hylkema BS, Haanen C Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999, 353:1675-1676.
151. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003, 42:211-216.
152. Klion AD, Law MA, Riemenschneider W, et al. Familial eosinophilia: a benign disorder?. Blood 2004, 103:4050-4055.